GlassScriptPhysician profile
Caitlin Cook
NPI 1184029175
$6,245.18
in general payments reported to CMS, 2019-2025
20 companies · $2,175 in 2025
The $2,175 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $854 · 2023: $874 · 2024: $2,342 · 2025: $2,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,301 · Education: $90.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,300.57 |
| Education | $90.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,993.46 | 2022-2025 | |
| Janssen Biotech, INC. | $1,074.58 | 2022-2025 | Tremfya, Stelara, Simponi |
| Novartis Pharmaceuticals Corporation | $756.81 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $719.67 | 2023-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $239.44 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $224.76 | 2023-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $204.98 | 2023-2025 | Ilumya, Winlevi, Absorica Ld |
| Amgen INC. | $202.62 | 2023-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $138.49 | 2025 | Nemluvio |
| Lilly USA, LLC | $133.48 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Alexion Pharmaceuticals, INC. | $122.88 | 2025 | Koselugo |
| Arcutis Biotherapeutics, INC. | $83.64 | 2023-2025 | Zoryve |
| Pfizer INC. | $80.65 | 2022-2025 | |
| Ucb, INC. | $70.38 | 2024 | Bimzelx |
| Sanofi-Aventis U.S. LLC | $59.99 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $38.33 | 2023-2024 | Vtama |
| Mallinckrodt Hospital Products INC. | $36.81 | 2025 | Acthar |
| Organon LLC | $28.12 | 2025 | |
| Blueprint Medicines Corporation | $22.58 | 2024 | Ayvakit |
| Helsinn Therapeutics (U.S.), INC. | $13.51 | 2025 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.